Dr Deborah Meyran
Honorary (Senior Fellow)
Department of Paediatrics
22 Scholarly works
5 Projects
HIGHLIGHTS
2025
Journal article
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors
DOI: 10.1038/s41467-025-59021-92025
Journal article
Co-designing a Novel Ordinal Endpoint for an Adaptive Platform Trial, BANDICOOT, in Pediatric Hematopoietic Stem Cell Transplant
DOI: 10.1016/j.jtct.2025.01.8942025
Journal article
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
DOI: 10.1158/1078-0432.CCR-24-05812024
Research grants (other domestic)
New Frontiers for CAR T Cell Therapy in Breast Cancer
2023
Journal article
Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia
DOI: 10.1111/tid.142022023
Research grants (ARC, NHMRC, MRFF)
Improving Outcomes for High-Risk Child and Adolescent Cancer: From Discovery to Individualised Treatment Within a Consumer Partnership
2023
Research grants (ARC, NHMRC, MRFF)
Improving Outcomes for High-Risk Child and Adolescent Cancer: From Discovery to Individualised Treatment Within a Consumer Partnership
RECENT SCHOLARLY WORKS
2023
Journal article
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
DOI: 10.1186/s13073-023-01170-x2023
Journal article
TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
DOI: 10.1126/scitranslmed.abk19002023
Journal article
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells
DOI: 10.3324/haematol.2021.2799302022
Journal article
Advances in CAR T cell immunotherapy for paediatric brain tumours
DOI: 10.3389/fonc.2022.8737222022
Conference Proceedings
PRECISION MEDICINE REVEALS A HETEROGENOUS TUMOUR IMMUNE MICROENVIRONMENT IN PAEDIATRIC GLIOMAS
2021
Journal article
Enhancing the potential of immunotherapy in paediatric sarcomas: Breaking the immunosuppressive barrier with receptor tyrosine kinase inhibitors
DOI: 10.3390/biomedicines9121798
RECENT PROJECTS
2023
Research grants (other domestic)
Targeting NAD Metabolism to Overcome Therapeutic Resistance in Adult and Paediatric Acute Myeloid Leukaemia
2024
Research grants (other domestic)
Advancing CAR-T Cell Therapy for Extracranial Solid Paediatric Cancer